Related Experiment Videos
Commitment of the teratocarcinoma-derived mesodermal clone C1 towards terminal osteogenic differentiation
A Poliard1, D Lamblin, P J Marie
1Laboratoire de Différenciation Cellulaire de l'Institut Pasteur, Unité Associée du Centre National de la Recherche Scientifique 1148, Paris, France.
Journal of Cell Science
|October 1, 1993
Summary
The C1 mesodermal stem cell clone differentiates into osteoblasts in vitro. Osteogenic commitment requires cell-cell contact and specific mediators like ascorbic acid and beta-glycerophosphate for mineralization.
Area of Science:
- Stem Cell Biology
- Bone Biology
- Developmental Biology
Background:
- The C1 clone, derived from embryonal carcinoma cells, is a multipotent mesodermal stem cell.
- Understanding osteogenesis in vitro is crucial for bone regeneration research.
Purpose of the Study:
- To validate the C1 clone as a model for studying osteogenesis in vitro.
- To investigate the kinetics and molecular mechanisms of C1 cell osteogenic differentiation.
Main Methods:
- Culture of C1 cells in aggregates with osteogenic differentiation mediators.
- Histological analysis of cell aggregates.
- Gene expression analysis of bone matrix proteins.
Main Results:
- Ascorbic acid and beta-glycerophosphate induced mineralization in nearly all aggregates.
- Cell-cell contact initiated gene transcription for bone matrix proteins.
- Osteocalcin and osteopontin transcripts accumulated in mineralizing areas.
- Type I collagen and osteocalcin were deposited extracellularly.
- Osteogenic differentiation occurred concurrently with cell proliferation.
Conclusions:
- The C1 clone serves as a promising in vitro model for osteoblast ontogeny.
- Osteogenic commitment is triggered by cell-cell contact and specific biochemical cues.
- This system facilitates deciphering the molecular basis of osteoblast development.